Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China-Reference-Cited by-同舟云学术

Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China

Published:2017-06-29 Issue:6 Volume:12 Page:e0180618
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhang Liran,Xie Fengxiang,Wang Xinguo,Peng Dezhi,Bi Chunrui,Jiang Lingbo,Zhao Dongman,Tian Xinxin,Qi Debo^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Review of the cervical cancer burden and population-based cervical cancer screening in China;J Di;Asian Pac J Cancer Prev,2015

2. The burden of cervical cancer in China: synthesis of the evidence;JF Shi;Int J Cancer,2012

3. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer;KL Wallin;N Engl J Med,1999

4. Human papillomavirus and cervical cancer;M Schiffman;Lancet,2007

5. Human papillomavirus and cervical cancer;EJ Crosbie;Lancet,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective analysis of cytology and high‐risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions;Cancer Cytopathology;2024-02-19

2. Comparative assessment of test characteristics of cervical cancer screening methods for implementation in low-resource settings;Preventive Medicine;2022-01

3. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan;Gynecologic Oncology;2021-05

4. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs;BMC Cancer;2020-08-26

5. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China’s largest independent operator of pathology laboratories;BMC Infectious Diseases;2019-11-11